Five-treatment radiation therapy offers an effective nonsurgical alternative for localized prostate cancer

AI Summary

A randomized trial found that five-session stereotactic body radiation therapy provided strong long-term cancer control for localized prostate cancer. Compared with surgery, the treatment was associated with fewer urinary and sexual side effects.

Five-treatment stereotactic body radiation therapy (SBRT) provided excellent long-term cancer control with fewer urinary and sexual side effects than surgery in the first randomized trial to directly compare the treatments for localized prostate cancer.